Literature DB >> 15812577

Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.

L Maïmoun1, I Couret, D Mariano-Goulart, A M Dupuy, J-P Micallef, E Peruchon, F Ohanna, J-P Cristol, M Rossi, J-L Leroux.   

Abstract

This study analyzed the temporal and regional variations in bone loss and explored bone cell activities via biochemical markers during an extended follow-up in patients with spinal cord injury (SCI). In parallel, the possible role of the osteoprotegerin (OPG)/RANKL system in disuse osteoporosis was investigated. Seven male patients with acute and complete SCI (31.3 +/- 9.5 years) and 12 able-bodied (AB) men (26.9 +/- 4.2 years) participated in the study. Measurements were performed 16, 24, 36, 48, and 71 weeks after injury. At week 16, marked calcium homeostasis disturbance and a concomitant increase in bone resorption markers were observed, reflecting an intense bone degradation process. Resorption activity decreased continuously with time. Contrasting with the great rise in the resorption markers, the bone formation markers showed little variation. During the period of investigation, a loss in bone mineral density (BMD) was demonstrated for the total body (-4.3%), pelvis (-15.7%) and lower limbs (-15.2%), whereas BMD did not change at the lumbar spine, upper limbs, or skull. At all stages, SCI patients had lower serum RANKL levels and higher serum OPG levels than did AB controls, but no significant variation with time was observed for either cytokine. These findings suggest that bone resorption persisted long after SCI and specifically affected BMD at sublesional sites. The marked modification of serum OPG/RANKL levels in SCI patients suggests that this system is affected, in disuse osteoporosis. However, the precise biologic role of the OPG/RANKL system in the bone tissue of SCI patients has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812577     DOI: 10.1007/s00223-004-0048-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  24 in total

1.  Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.

Authors:  L Gifre; J Vidal; J L Carrasco; A Muxi; E Portell; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

2.  Bone loss following spinal cord injury in a rat model.

Authors:  Michael J Voor; Edward H Brown; Qian Xu; Seid W Waddell; Robert L Burden; Darlene A Burke; David S K Magnuson
Journal:  J Neurotrauma       Date:  2012-02-22       Impact factor: 5.269

3.  Bone marrow changes related to disuse.

Authors:  Lorenzo Nardo; David N Sandman; Warapat Virayavanich; Linlin Zhang; Richard B Souza; Lynne Steinbach; Michele Guindani; Thomas M Link
Journal:  Eur Radiol       Date:  2013-07-07       Impact factor: 5.315

Review 4.  Relationship between serum RANKL and RANKL in bone.

Authors:  D M Findlay; G J Atkins
Journal:  Osteoporos Int       Date:  2011-08-18       Impact factor: 4.507

5.  Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats.

Authors:  S-D Jiang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2006-10-12       Impact factor: 4.507

6.  Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.

Authors:  L Gifre; S Ruiz-Gaspà; J L Carrasco; E Portell; J Vidal; A Muxi; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2017-06-04       Impact factor: 4.507

7.  Agreement between fragility fracture risk assessment algorithms as applied to adults with chronic spinal cord injury.

Authors:  T Cervinka; C L Lynch; L Giangregorio; J D Adachi; A Papaioannou; L Thabane; B C Craven
Journal:  Spinal Cord       Date:  2017-06-13       Impact factor: 2.772

8.  Effects of electromyostimulation on muscle and bone in men with acute traumatic spinal cord injury: A randomized clinical trial.

Authors:  Alfredo Arija-Blázquez; Silvia Ceruelo-Abajo; María S Díaz-Merino; Juan Antonio Godino-Durán; Luís Martínez-Dhier; José L R Martin; José Florensa-Vila
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

9.  Prolonged unilateral disuse osteopenia 14 years post external fixator removal: a case history and critical review.

Authors:  Karen M Knapp; Ann V Rowlands; Joanne R Welsman; Kenneth M Macleod
Journal:  Case Rep Med       Date:  2010-04-21

10.  The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.

Authors:  Inaam A Nakchbandi; Robert Lang; Barbara Kinder; Karl L Insogna
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.